Ligand profile
A05
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_2384 — methionine aminopeptidase, type I
Identifiers
Database identifiers and provenance.
- Ligand ID
A05- PDB
2q95- UniProt (similar protein)
P0AE18- Target protein
- VK055_2384
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 93.6
- −1 ≤ LogP ≤ 5 3.21
- MW ≤ 500 Da 267.6
- LogP ≤ 5 3.21
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 93.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(c(cc1[N+](=O)[O-])Cl)c2ccc(o2)C(=O)Oc1cc(c(cc1[N+](=O)[O-])Cl)c2ccc(o2)C(=O)O
InChI=1S/C11H6ClNO5/c12-8-5-6(13(16)17)1-2-7(8)9-3-4-10(18-9)11(14)15/h1-5H,(H,14,15)InChI=1S/C11H6ClNO5/c12-8-5-6(13(16)17)1-2-7(8)9-3-4-10(18-9)11(14)15/h1-5H,(H,14,15)
HDIHNBCCQWMVBW-UHFFFAOYSA-NHDIHNBCCQWMVBW-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00557
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand A05 →
- PDB RCSB structure 2q95 →
- UniProt UniProt P0AE18 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “A05”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2384.
PDB 45
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).